A comparison of the baseline characteristics between the participants retained in follow-up (n = 303) and those lost to follow-up (n = 202) showed no major differences in sex, liver cirrhosis status, or key laboratory markers such as ALT, AST, platelet count, APRI, and FIB-4 scores (Supplementary Table S1). This evidence concerns the gene GPT and cirrhosis of liver.